RHEA VOTIPKA: Open Payments
NPI 1750773941 · BURLINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 9 payments from 4 companies in 2025. Trend: 2023 $164 · 2024 $96 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $356 |
| United Therapeutics Corporation | 3 | $267 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| Verona Pharma, Inc. | 1 | $35 |
Products named: DUPIXENT, BREZTRI, STEEN SOLUTION, Ohtuvayre.
Industry payments across MA — which companies pay providers there.
